Found: 29
Select item for more details and to access through your institution.
Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 7, p. 1197, doi. 10.1007/s00432-012-1183-5
- By:
- Publication type:
- Article
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 10, p. 780, doi. 10.1007/s12094-013-1001-9
- By:
- Publication type:
- Article
CD44/CD24 breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 1, p. 46, doi. 10.1007/s12094-012-0891-2
- By:
- Publication type:
- Article
Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 10, p. 764, doi. 10.1007/s12094-012-0860-9
- By:
- Publication type:
- Article
Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 8, p. 575, doi. 10.1007/s12094-012-0844-9
- By:
- Publication type:
- Article
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 3, p. 543, doi. 10.1007/s10549-024-07323-9
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin (Duomeisu<sup>®</sup>) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 67, doi. 10.1007/s10549-023-06894-3
- By:
- Publication type:
- Article
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 725, doi. 10.1007/s10549-021-06345-x
- By:
- Publication type:
- Article
Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1076469
- By:
- Publication type:
- Article
Predominant sarcomatoid carcinoma of the lung concurrent with jejunal metastasis and leukocytosis.
- Published in:
- Rare Tumors, 2010, v. 2, n. 3, p. 120, doi. 10.4081/rt.2010.e44
- By:
- Publication type:
- Article
Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 4, p. 396, doi. 10.1111/ajco.13528
- By:
- Publication type:
- Article
Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 795, doi. 10.4143/crt.2023.1151
- By:
- Publication type:
- Article
Elevated level of peripheral CD8CD28 T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1123, doi. 10.1007/s00262-013-1424-8
- By:
- Publication type:
- Article
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2239788, doi. 10.1001/jamanetworkopen.2022.39788
- By:
- Publication type:
- Article
Effects of different Chinese herbal prescriptions on cytokines in autoimmune prostatitis rats.
- Published in:
- Journal of Traditional Chinese Medicine, 2015, v. 35, n. 2, p. 211, doi. 10.1016/s0254-6272(15)30030-3
- By:
- Publication type:
- Article
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2‐ metastatic breast cancer: A single center real‐world study in China.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 10, p. 1, doi. 10.1002/cam4.7249
- By:
- Publication type:
- Article
Bilateral breast cancer in China: A 10‐year single‐center retrospective study (2006–2016).
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 6089, doi. 10.1002/cam4.4141
- By:
- Publication type:
- Article
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 3, p. 547, doi. 10.1002/cam4.1004
- By:
- Publication type:
- Article
HER2 status results in an unstable switch from primary to recurrent breast cancer.
- Published in:
- Neoplasma, 2024, v. 71, n. 4, p. 392, doi. 10.4149/neo_2024_240229N89
- By:
- Publication type:
- Article
CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 917, doi. 10.32604/or.2023.030425
- By:
- Publication type:
- Article
Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study.
- Published in:
- Oncologist, 2024, v. 29, n. 2, p. e198, doi. 10.1093/oncolo/oyad228
- By:
- Publication type:
- Article
Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1102, doi. 10.1093/oncolo/oyad288
- By:
- Publication type:
- Article
First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients.
- Published in:
- Oncology Letters, 2015, v. 9, n. 2, p. 987, doi. 10.3892/ol.2014.2787
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.971594
- By:
- Publication type:
- Article
Dendritic cells pulsed with α-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
- Published in:
- Cancer Science, 2008, v. 99, n. 7, p. 1420, doi. 10.1111/j.1349-7006.2008.00820.x
- By:
- Publication type:
- Article
Comparison of renal clearance of [<sup>18</sup>F]AlF-RESCA-HER2-BCH and [<sup>18</sup>F]AlF-NOTA-HER2-BCH in mice and breast cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2775, doi. 10.1007/s00259-023-06232-1
- By:
- Publication type:
- Article
Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 8, p. 1348, doi. 10.1111/j.1440-1746.2012.07131.x
- By:
- Publication type:
- Article
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 4, p. 573, doi. 10.7150/jca.82291
- By:
- Publication type:
- Article
Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer.
- Published in:
- Current Oncology, 2022, v. 29, n. 9, p. 6154, doi. 10.3390/curroncol29090483
- By:
- Publication type:
- Article